Maximus, Inc. (MMS) - Q3 2024 10-Q Summary
Business Context and Reporting Period
Maximus, Inc. is a leading provider of government services worldwide, operating through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. This report covers the quarterly period ended June 30, 2024 (Q3 of Fiscal Year 2024). The company reported strong organic growth driven by volume increases in clinical services and Medicaid-related activities.
Key Financial Metrics
| Metric | Q3 2024 (3 Months) | Q3 2023 (3 Months) | YTD 2024 (9 Months) | YTD 2023 (9 Months) |
|---|---|---|---|---|
| Revenue | $1,314.9 million | $1,188.7 million | $3,990.3 million | $3,644.8 million |
| Gross Profit | $332.3 million (25.3%) | $264.4 million (22.2%) | $949.9 million (23.8%) | $737.7 million (20.2%) |
| Operating Income | $141.7 million (10.8%) | $58.4 million (4.9%) | $376.7 million (9.4%) | $195.7 million (5.4%) |
| Net Income | $89.8 million | $30.9 million | $234.4 million | $102.6 million |
| Diluted EPS | $1.46 | $0.50 | $3.81 | $1.67 |
| Operating Cash Flow (YTD) | $351.4 million | |||
| Free Cash Flow (YTD) | $269.2 million | |||
| Total Debt (Principal) | $1.155 billion | |||
| Cash & Equivalents | $102.8 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 10.6% in Q3 and 9.5% YTD, driven primarily by organic growth in the U.S. Federal Services (17.0% Q3 growth) and U.S. Services (5.2% Q3 growth) segments.
- Margin Expansion: Operating margin improved significantly to 10.8% in Q3 from 4.9% in the prior year. This was aided by the absence of $22.1 million in cybersecurity investigation costs that impacted Q3 2023 SG&A expenses.
- Segment Performance:
- U.S. Federal Services: Revenue up 17.0% Q3; operating margin expanded to 15.5% due to volume growth in clinical assessments.
- U.S. Services: Revenue up 5.2% Q3; operating margin improved to 13.0% as Medicaid redetermination volumes increased.
- Outside the U.S.: Revenue up 2.3% Q3; operating loss narrowed significantly to $1.4 million from $15.2 million in the prior year, aided by divestitures and currency benefits.
- Debt Restructuring: In May 2024, the company amended its credit agreement, extending maturities to 2029 and 2031 and rebalancing borrowings. Total debt principal decreased to $1.155 billion from $1.258 billion at the prior year-end.
Guidance, Outlook, and Risks
- Outlook: Management anticipates full-year operating margins of approximately 12.5% for U.S. Federal Services and 13% for U.S. Services. The Outside the U.S. segment is expected to yield slightly above break-even operating margin for the full year.
- Contract Recompites: The company is monitoring two significant recompetes:
- Medicare & Medicaid Services Contact Center: A $6.6 billion contract (approx. 10-15% of annual revenue) is being recompeted earlier than expected. Maximus has filed a pre-award protest.
- VA Medical Disability Examinations (MDE): Contracts representing 10-15% of revenue are subject to rebid due to volume increases under the PACT Act.
- Cybersecurity Litigation: Multiple class actions and individual suits remain pending regarding the May 2023 MOVEit cybersecurity incident. The company cannot predict the ultimate outcome or loss.
- DOJ Investigation: A Civil Investigation Demand (CID) regarding the Census project remains open. The company has reserved $4.0 million, though additional losses are reasonably possible.
- Capital Allocation: The company continues to prioritize debt reduction using free cash flow. A $200 million share repurchase program was authorized in June 2024; $50.6 million was utilized in the first nine months of FY2024.
Key Investor Verification Points
- Contract Recompete Outcomes: Verify the status of the pre-award protest for the CMS Contact Center contract and the rebid process for VA MDE contracts, as these represent significant revenue exposure.
- Cybersecurity Liability: Monitor developments in the MOVEit litigation and the DOJ Census investigation to assess potential financial impact beyond the current $4.0 million reserve.
- Debt Covenants: Confirm continued compliance with the Amended Credit Agreement covenants, specifically the Consolidated Net Total Leverage Ratio (currently 1.47x vs. 4.00x limit).
- Intangible Asset Amortization: Note the acceleration of amortization for certain technology assets acquired in 2021, effective July 1, 2024, which may impact future earnings.